• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 3. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 4. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 5. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431

Professional Introduction to 4-(3-fluorophenyl)-2-methyl-4-oxobutanoic Acid (CAS No. 75380-94-8)

4-(3-fluorophenyl)-2-methyl-4-oxobutanoic acid, identified by its Chemical Abstracts Service registry number CAS No. 75380-94-8, is a significant compound in the realm of pharmaceutical and chemical research. This compound, featuring a unique structural arrangement, has garnered attention due to its potential applications in drug development and synthetic chemistry. The presence of a fluorophenyl moiety and an oxobutanoic acid backbone imparts distinct chemical properties that make it a valuable intermediate in various synthetic pathways.

The molecular structure of 4-(3-fluorophenyl)-2-methyl-4-oxobutanoic acid consists of a benzene ring substituted with a fluorine atom at the 3-position, connected to a butanoic acid derivative through a methyl group and an oxygen atom. This configuration contributes to its reactivity and makes it a versatile building block for more complex molecules. The compound's stability under various conditions and its ability to undergo selective modifications have positioned it as a candidate for further exploration in medicinal chemistry.

In recent years, the pharmaceutical industry has shown increasing interest in fluorinated compounds due to their enhanced metabolic stability and binding affinity. The fluorophenyl group in 4-(3-fluorophenyl)-2-methyl-4-oxobutanoic acid is particularly noteworthy, as fluorine atoms can influence the electronic properties of adjacent atoms, thereby affecting the compound's biological activity. This feature has been exploited in the design of novel therapeutic agents targeting various diseases, including cancer and inflammatory disorders.

One of the most compelling aspects of this compound is its role in the synthesis of bioactive molecules. Researchers have utilized 4-(3-fluorophenyl)-2-methyl-4-oxobutanoic acid as a precursor in the development of kinase inhibitors, which are crucial in treating cancers and autoimmune diseases. The oxobutanoic acid moiety provides a scaffold that can be modified to achieve specific pharmacological effects. For instance, studies have demonstrated its utility in creating compounds that selectively inhibit certain enzymes implicated in disease pathways.

The synthesis of 4-(3-fluorophenyl)-2-methyl-4-oxobutanoic acid involves multi-step organic reactions that highlight its synthetic versatility. Advanced techniques such as palladium-catalyzed cross-coupling reactions have been employed to introduce the fluorophenyl group efficiently. These methods not only ensure high yields but also minimize byproduct formation, making the process environmentally friendly and economically viable.

Recent advancements in computational chemistry have further enhanced the understanding of this compound's properties. Molecular modeling studies have predicted that 4-(3-fluorophenyl)-2-methyl-4-oxobutanoic acid can form stable interactions with biological targets, suggesting its potential as an active pharmaceutical ingredient (API). These predictions are supported by experimental data showing favorable binding affinities and pharmacokinetic profiles.

The compound's applications extend beyond drug development into materials science. Its unique structural features make it suitable for designing functional materials with specific properties. For example, researchers have explored its use in creating polymers with enhanced thermal stability and mechanical strength. These materials could find applications in high-performance coatings and advanced composites.

In conclusion, 4-(3-fluorophenyl)-2-methyl-4-oxobutanoic acid (CAS No. 75380-94-8) is a multifaceted compound with significant potential in pharmaceuticals and materials science. Its structural characteristics, coupled with recent advancements in synthetic and computational chemistry, make it a promising candidate for further research and development. As the scientific community continues to uncover new applications for this compound, its importance is likely to grow, contributing to innovations across multiple industries.

• 69797-46-2(4-(3-Fluorophenyl)-4-oxobutanoic acid)
• 735275-19-1( )
• 735275-18-0( )
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)